文献速递临床生化临床免疫质量管理与危急值

MAGLUMI CLIA高敏心肌肌钙蛋白I方法的分析性能与99百分位参考上限多中心研究

Analytical characteristics and performance of a new hs-cTnI method: a multicenter-study.
PubMed 文献 · Clin Chem Lab Med · 2025-01-07

这项多中心研究评估了MAGLUMI® CLIA高敏心肌肌钙蛋白I(hs-cTnI)方法的分析性能和参考健康人群99百分位上限(URL)。研究纳入989名18-70岁献血志愿者和47名≥71岁健康个体,结果显示hs-cTnI水平在男性中显著高于女性(p=0.0028),且55岁后随年龄递增;总人群99百分位URL为7.18 ng/L(95%CI 6.08-12.20)。该方法满足国际指南对hs-cTnI测定的所有推荐标准。

要点

  • 男性hs-cTnI水平显著高于同年龄女性(p=0.0028)。
  • 55岁后男女hs-cTnI水平均随年龄递增。
  • 总人群99百分位URL为7.18 ng/L(95%CI 6.08-12.20)。

核心结论

  • MAGLUMI CLIA方法满足国际指南推荐的hs-cTnI测定全部标准。
  • hs-cTnI水平在男性中高于女性,且在55岁后随年龄递增。

研究设计与样本

  • 多中心研究,采用经验证和标准化的实验方案评估CLIA法hs-cTnI的分析性能及99百分位URL。
  • 第一队列纳入989名18-70岁献血志愿者(489女,500男;平均年龄43岁,IQR 31-54岁)。
  • 第二队列纳入47名≥71岁健康个体(31女,16男;平均年龄78岁,IQR 73-81岁)。

主要发现

  • hs-cTnI水平在男女中均呈高度右偏分布,男性显著高于女性(p=0.0028)。
  • 男女hs-cTnI水平在55岁后均逐步升高。
  • 多变量分析(n=958)显示hs-cTnI与NT-proBNP(p<0.0001)、性别(p<0.0001)和BMI(p=0.0424)显著相关。

关键数值与推荐

  • 女性(n=521)99百分位URL:5.93 ng/L(95%CI 5.29-8.48)。
  • 男性(n=516)99百分位URL:9.79 ng/L(95%CI 6.37-17.41 ng/L)。
  • 总人群(n=1,037)99百分位URL:7.18 ng/L(95%CI 6.08-12.20 ng/L)。

临床怎么用

  • 临床解读hs-cTnI时应考虑性别和年龄(尤其55岁以上)对参考值的影响。
  • 该方法的99百分位URL可用于hs-cTnI检测的临床决策参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The present multicenter study was designed to evaluate the analytical performance and the 99th percentile value of the reference healthy population i.e., 99th percentile upper reference limit of the MAGLUMI® CLIA high-sensitivity cardiac troponin I (hs-cTnI) method. METHODS: Analytical performances and the 99th percentile URL value of the chemi-luminescent-immuno-assay (CLIA) method were evaluated using validated and standardized experimental protocols. Two cohorts including healthy adult individuals were enrolled. The first one included 989 blood donor volunteers (489 women and 500 men) aged 18-70 years (mean age 43 years, interquartile range 31-54 years). The second population included 47 healthy individuals (31 women and 16 men, mean age 78 years, interquartile range 73-81 years) aged≥71 years. RESULTS: The distributions of hs-cTnI levels in both sexes are highly right-skewed, and men show significantly (p=0.0028) higher biomarker values than women. Moreover, in both sexes the hs-cTnI levels progressively increase after the 55 years. In the multivariate analysis (n=958), hs-cTnI was found to be significantly associated to NT-proBNP (p<0.0001), sex (p<0.0001) and BMI (p=0.0424). The 99th percentile URL values, calculated using the bootstrap method in the total reference heathy population (age≥18 years), were: Females (n=521): 5.93 ng/L (CI 95 % 5.29-8.48), Males (n=516): 9.79 ng/L (CI 95 % 6.37-17.41 ng/L), Total Population (n=1,037): 7.18 ng/L (CI 6.08-12.20 ng/L). CONCLUSIONS: The MAGLUMI CLIA method met all the criteria for an hs-cTnI assay recommended by international guidelines. The hs-cTnI values measured with the CLIA method are higher in men compared to women at the same age, and also progressively increase after the age>55 years.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Fasano T, Fortunato A, Giacomini G, et al. Analytical characteristics and performance of a new hs-cTnI method: a multicenter-study. Clin Chem Lab Med. 2025. PMID: 39760443. doi:10.1515/cclm-2024-0905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。